Dicerna Pharmaceuticals reported $107.66M in Equity Capital and Reserves for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Equity Capital And Reserves Change
Acceleron Pharma XLRN:US $ 718.15M 44.88M
Alnylam Pharmaceuticals ALNY:US $ 755.89M 97.47M
Amgen AMGN:US $ 8217M 30M
Arrowhead Research ARWR:US $ 408.82M 28.07M
Biogen BIIB:US $ 10429.9M 322M
Bluebird Bio BLUE:US $ 870.53M 114.03M
Dicerna Pharmaceuticals DRNA:US $ 107.66M 3.41M
Exelixis EXEL:US $ 2112.45M 69.37M
Gilead Sciences GILD:US $ 21471M 1768M
GlaxoSmithKline GSK:LN 15426M 49M
Immunogen IMGN:US $ 77.09M 8.63M
Intercept Pharmaceuticals ICPT:US $ -156.03M 47.16M
Intrexon XON:US $ 131.25M 27.95M
IONIS PHARMACEUT IONS:US $ 531M 51.67M
Karyopharm Therapeutics KPTI:US $ -125977000 42.84M
Lexicon Pharmaceuticals LXRX:US $ 136.6M 630K
Macrogenics MGNX:US $ 291.44M 27.61M
Mirati Therapeutics MRTX:US $ 1084.03M 44.9M
Regeneron Pharmaceuticals REGN:US $ 17258M 2130.7M
Ultragenyx Pharmaceutical RARE:US $ 933.67M 38.5M